138 related articles for article (PubMed ID: 31163444)
1. A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.
Beurmanjer H; Asperslag EM; Oliemeulen L; Goudriaan AE; De Jong CAJ; Schellekens ASA; Dijkstra BAG
Eur Addict Res; 2019; 25(5):248-255. PubMed ID: 31163444
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Impairments in Patients with GHB Use Disorder Predict Relapse in GHB Use.
Beurmanjer H; Bruijnen CJWH; Greeven PGJ; De Jong CAJ; Schellekens AFA; Dijkstra BAG
Eur Addict Res; 2022; 28(5):350-357. PubMed ID: 35853435
[TBL] [Abstract][Full Text] [Related]
3. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
5. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
6. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
7. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
[TBL] [Abstract][Full Text] [Related]
8. Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.
Brunt TM; Koeter MW; Hertoghs N; van Noorden MS; van den Brink W
Drug Alcohol Depend; 2013 Aug; 131(3):316-9. PubMed ID: 23332440
[TBL] [Abstract][Full Text] [Related]
9. [Course and complications of GHB detoxification treatment: a 1-year case series].
Neu P
Nervenarzt; 2019 May; 90(5):509-515. PubMed ID: 30362026
[TBL] [Abstract][Full Text] [Related]
10. Inpatient management of gamma-hydroxybutyrate withdrawal.
Cappetta M; Murnion BP
Australas Psychiatry; 2019 Jun; 27(3):284-287. PubMed ID: 30652947
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
12. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
Busardò FP; Jones AW
Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
Brennan R; Van Hout MC
J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
[TBL] [Abstract][Full Text] [Related]
14. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
Richter C; Romanowski A; Kienast T
Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
[TBL] [Abstract][Full Text] [Related]
15. Substance use disorders and sexual behavior; the effects of alcohol and drugs on patients' sexual thoughts, feelings and behavior.
Bosma-Bleeker MH; Blaauw E
Addict Behav; 2018 Dec; 87():231-237. PubMed ID: 30077915
[TBL] [Abstract][Full Text] [Related]
16. Inpatient management of GHB/GBL withdrawal.
Delic M
Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
[TBL] [Abstract][Full Text] [Related]
17. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
18. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric comorbidity, psychological distress, and quality of life in gamma-hydroxybutyrate-dependent patients.
Kamal RM; Dijkstra BA; de Weert-van Oene GH; van Duren JA; de Jong CA
J Addict Dis; 2017; 36(1):72-79. PubMed ID: 27449738
[TBL] [Abstract][Full Text] [Related]
20. GHB: a life-threatening drug complications and outcome of GHB detoxification treatment-an observational clinical study.
Neu P; Danker-Hopfe H; Fisher R; Ehlen F
Addict Sci Clin Pract; 2023 Oct; 18(1):62. PubMed ID: 37864267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
